Thomas Jensen

CEO

Chief Executive Officer

US·SEC (Form 4)

Allarity Therapeutics, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 14 May 2026 for Allarity Therapeutics, Inc..

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Thomas Jensen: trading record in brief

All filings by Thomas Jensen on record concern Allarity Therapeutics, Inc., in the capacity of chief executive. The record holds 2 filings, for trades running from 22 January 2025 to 28 January 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 14 May 2026, reports a share grant in Allarity Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.